|
1
|
Baccaro LF, Conde DM, Costa-Paiva L and
Pinto-Neto AM: The epidemiology and management of postmenopausal
osteoporosis: A viewpoint from Brazil. Clin Interv Aging.
10:583–591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Q, Shou P, Zhang L, Xu C, Zheng C,
Han Y, Li W, Huang Y, Zhang X, Shao C, et al: An
osteopontin-integrin interaction plays a critical role in directing
adipogenesis and osteogenesis by mesenchymal stem cells. Stem
Cells. 32:327–337. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Camacho PM, Petak SM, Binkley N, Clarke
BL, Harris ST, Hurley DL, Kleerekoper M, Lewiecki EM, Miller PD,
Narula HS, et al: American association of clinical endocrinologists
and American college of endocrinology clinical practice guidelines
for the diagnosis and treatment of postmenopausal
osteoporosis-2016-executive summary. Endocr Pract. 22:1111–1118.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu D, Gao Y, Hu N, Wu L and Chen Q:
miR-365 ameliorates dexamethasone-induced suppression of
osteogenesis in MC3T3-E1 cells by targeting HDAC4. Int J Mol Sci.
18:E9772017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuasa M, Yamada T, Taniyama T, Masaoka T,
Xuetao W, Yoshii T, Horie M, Yasuda H, Uemura T, Okawa A and Sotome
S: Dexamethasone enhances osteogenic differentiation of bone
marrow- and muscle-derived stromal cells and augments ectopic bone
formation induced by bone morphogenetic protein-2. PLoS One.
10:e01164622015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fardet L, Petersen I and Nazareth I:
Prevalence of long-term oral glucocorticoid prescriptions in the UK
over the past 20 years. Rheumatology (Oxford). 50:1982–1990. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hoes JN, Bultink IE and Lems WF:
Management of osteoporosis in rheumatoid arthritis patients. Expert
Opin Pharmacother. 16:559–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Edens C and Robinson AB: Systemic lupus
erythematosus, bone health, and osteoporosis. Curr Opin Endocrinol
Diabetes Obes. 22:422–431. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Monadi M, Javadian Y, Cheraghi M, Heidari
B and Amiri M: Impact of treatment with inhaled corticosteroids on
bone mineral density of patients with asthma: Related with age.
Osteoporos Int. 26:2013–2018. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Caramori G, Ruggeri P, Arpinelli F, Salvi
L and Girbino G: Long-term use of inhaled glucocorticoids in
patients with stable chronic obstructive pulmonary disease and risk
of bone fractures: A narrative review of the literature. Int J
Chron Obstruct Pulmon Dis. 14:1085–1097. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krela-Kaźmierczak I, Szymczak A,
Łykowska-Szuber L, Eder P and Linke K: Osteoporosis in
gastrointestinal diseases. Adv Clin Exp Med. 25:185–190. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kitazaki S, Mitsuyama K, Masuda J, Harada
K, Yamasaki H, Kuwaki K, Takedatsu H, Sugiyama G, Tsuruta O and
Sata M: Clinical trial: Comparison of alendronate and alfacalcidol
in glucocorticoid-associated osteoporosis in patients with
ulcerative colitis. Aliment Pharmacol Ther. 29:424–430. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li J, Zhang N, Huang X, Xu J, Fernandes
JC, Dai K and Zhang X: Dexamethasone shifts bone marrow stromal
cells from osteoblasts to adipocytes by C/EBPalpha promoter
methylation. Cell Death Dis. 4:e8322013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sosa M and Gomez de Tejada MJ:
Glucocorticoid-Induced osteoporosis. N Engl J Med. 380:1378–1379.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang X, Hu X, Yang Y, Takata T and Sakurai
T: Nicotinamide mononucleotide protects against β-amyloid
oligomer-induced cognitive impairment and neuronal death. Brain
Res. 1643:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song J, Li J, Yang F, Ning G, Zhen L, Wu
L, Zheng Y, Zhang Q, Lin D, Xie C and Peng L: Nicotinamide
mononucleotide promotes osteogenesis and reduces adipogenesis by
regulating mesenchymal stromal cells via the SIRT1 pathway in aged
bone marrow. Cell Death Dis. 10:3362019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Signer RA and Morrison SJ: Mechanisms that
regulate stem cell aging and life span. Cell Stem Cell. 12:152–165.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frye RA: Characterization of five human
cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins
(sirtuins) metabolize NAD and may have protein
ADP-ribosyltransferase activity. Biochem Biophys Res Commun.
260:273–279. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sherman JM, Stone EM, Freeman-Cook LL,
Brachmann CB, Boeke JD and Pillus L: The conserved core of a human
SIR2 homologue functions in yeast silencing. Mol Biol Cell.
10:3045–3059. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang F, Kume S and Koya D: SIRT1 and
insulin resistance. Nat Rev Endocrinol. 5:367–373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chua KF, Mostoslavsky R, Lombard DB, Pang
WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N,
et al: Mammalian SIRT1 limits replicative life span in response to
chronic genotoxic stress. Cell Metab. 2:67–76. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Haigis MC and Guarente LP: Mammalian
sirtuins-emerging roles in physiology, aging, and calorie
restriction. Genes Dev. 20:2913–2921. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Leibiger IB and Berggren PO: Sirt1: A
metabolic master switch that modulates lifespan. Nat Med. 12:34–36;
discussion 36. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee HW, Suh JH, Kim AY, Lee YS, Park SY
and Kim JB: Histone deacetylase 1-mediated histone modification
regulates osteoblast differentiation. Mol Endocrinol. 20:2432–2443.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cohen-Kfir E, Artsi H, Levin A, Abramowitz
E, Bajayo A, Gurt I, Zhong L, D'Urso A, Toiber D, Mostoslavsky R
and Dresner-Pollak R: Sirt1 is a regulator of bone mass and a
repressor of Sost encoding for sclerostin, a bone formation
inhibitor. Endocrinology. 152:4514–4524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iyer S, Han L, Bartell SM, Kim HN, Gubrij
I, de Cabo R, O'Brien CA, Manolagas SC and Almeida M: Sirtuin1
(Sirt1) promotes cortical bone formation by preventing beta-catenin
sequestration by FoxO transcription factors in osteoblast
progenitors. J Biol Chem. 289:24069–24078. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun W, Qiao W, Zhou B, Hu Z, Yan Q, Wu J,
Wang R, Zhang Q and Miao D: Overexpression of Sirt1 in mesenchymal
stem cells protects against bone loss in mice by FOXO3a
deacetylation and oxidative stress inhibition. Metabolism.
88:61–71. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu W, Zhu C, Xu W, Jiang L and Jiang S:
Neuropeptide Y1 receptor regulates glucocorticoid-induced
inhibition of osteoblast differentiation in murine MC3T3-E1 cells
via ERK signaling. Int J Mol Sci. 17:E21502016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang Z, Hu B, Zang F, Wang J, Zhang X and
Chen H: Nrf2 drives oxidative stress-induced autophagy in nucleus
pulposus cells via a Keap1/Nrf2/p62 feedback loop to protect
intervertebral disc from degeneration. Cell Death Dis. 10:5102019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi GX, Zheng XF, Zhu C, Li B, Wang YR,
Jiang SD and Jiang LS: Evidence of the role of R-Spondin 1 and its
receptor Lgr4 in the transmission of mechanical stimuli to
biological signals for bone formation. Int J Mol Sci. 18:E5642017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lane NE: Glucocorticoid-Induced
osteoporosis: New insights into the pathophysiology and treatments.
Curr Osteoporos Rep. 17:1–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ohnaka K, Tanabe M, Kawate H, Nawata H and
Takayanagi R: Glucocorticoid suppresses the canonical Wnt signal in
cultured human osteoblasts. Biochem Biophys Res Commun.
329:177–181. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Briot K and Roux C: Glucocorticoid-induced
osteoporosis. RMD Open. 1:e0000142015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nogueiras R, Habegger KM, Chaudhary N,
Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA, Pfluger PT
and Tschöp MH: Sirtuin 1 and sirtuin 3: Physiological modulators of
metabolism. Physiol Rev. 92:1479–1514. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jung HY, Lee D, Ryu HG, Choi BH, Go Y, Lee
N, Lee D, Son HG, Jeon J, Kim SH, et al: Myricetin improves
endurance capacity and mitochondrial density by activating SIRT1
and PGC-1α. Sci Rep. 7:62372017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Henneicke H, Gasparini SJ,
Brennan-Speranza TC, Zhou H and Seibel MJ: Glucocorticoids and
bone: Local effects and systemic implications. Trends Endocrinol
Metab. 25:197–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Canalis E, Mazziotti G, Giustina A and
Bilezikian JP: Glucocorticoid-induced osteoporosis: Pathophysiology
and therapy. Osteoporos Int. 18:1319–1328. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Infante A and Rodriguez CI: Osteogenesis
and aging: Lessons from mesenchymal stem cells. Stem Cell Res Ther.
9:2442018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chen TL: Inhibition of growth and
differentiation of osteoprogenitors in mouse bone marrow stromal
cell cultures by increased donor age and glucocorticoid treatment.
Bone. 35:83–95. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, He J, He X, Li Y and Lindgren U:
Nampt expression increases during osteogenic differentiation of
multi- and omnipotent progenitors. Biochem Biophys Res Commun.
434:117–123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang H, Gao J, Zhang C, Li C and Wang Q,
Fan J, Wu Z and Wang Q: Nicotinamide mononucleotide alleviates
Aluminum induced bone loss by inhibiting the TXNIP-NLRP3
inflammasome. Toxicol Appl Pharmacol. 362:20–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qu H, Li T, Jin H, Zhang S and He B:
Silent mating type information regulation 2 homolog (SIRT1)
influences osteogenic proliferation and differentiation of MC3T3-E1
cells via regulation of miR-132-3p. Med Sci Monit. 25:2289–2295.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Wang H, Hu Z, Wu J, Mei Y, Zhang Q, Zhang
H, Miao D and Sun W: Sirt1 promotes osteogenic differentiation and
increases alveolar bone mass via Bmi1 activation in mice. J Bone
Miner Res. 34:1169–1181. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zainabadi K: Drugs targeting SIRT1, a new
generation of therapeutics for osteoporosis and other bone related
disorders? Pharmacol Res. 143:97–105. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hassan B, Baroukh B, Llorens A, Lesieur J,
Ribbes S, Chaussain C, Saffar JL and Gosset M: NAMPT expression in
osteoblasts controls osteoclast recruitment in alveolar bone
remodeling. J Cell Physiol. 233:7402–7414. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mills KF, Yoshida S, Stein LR, Grozio A,
Kubota S, Sasaki Y, Redpath P, Migaud ME, Apte RS, Uchida K, et al:
Long-term administration of nicotinamide mononucleotide mitigates
age-associated physiological decline in mice. Cell Metab.
24:795–806. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Baek JM, Ahn SJ, Cheon YH, Lee MS, Oh J
and Kim JY: Nicotinamide phosphoribosyltransferase inhibits
receptor activator of nuclear factor-kB ligand-induced osteoclast
differentiation in vitro. Mol Med Rep. 15:784–792. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Abed É, Couchourel D, Delalandre A, Duval
N, Pelletier JP, Martel-Pelletier J and Lajeunesse D: Low sirtuin 1
levels in human osteoarthritis subchondral osteoblasts lead to
abnormal sclerostin expression which decreases Wnt/β-catenin
activity. Bone. 59:28–36. 2014. View Article : Google Scholar : PubMed/NCBI
|
